Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Whether the differences in activities of CYP2A6 and DPD affect pharmacokinetics and pharmacodynamics of S-1 and clinical outcomes

Principal Investigator

Naohito Shirai, MD., PhD

Investigator Role:

Study Chair

Investigator Affiliation:

Department Laboratory Medicine, Hamamatsu University School of Medicine

Authority:

Japan: Ministry of Health, Labor and Welfare

Study ID:

S-12005

NCT ID:

NCT00197431

Start Date:

January 2004

Completion Date:

Related Keywords:

• Gastric Cancer
• Esophageal Cancer
• Pancreatic Cancer
• Colon Cancer
• Colonic Neoplasms
• Esophageal Diseases
• Esophageal Neoplasms
• Stomach Neoplasms
• Pancreatic Neoplasms